OMATEX Medical Technologies

SOMATEX is a German medical device company focused on minimally invasive single-use devices used in tumor diagnostics, biopsy procedures, and localization technologies, with particular strength in breast health. The company is best known for biopsy site markers and wire-free or minimally invasive localization products that support breast lesion marking and surgical guidance. SOMATEX also has product activities in assisted reproduction and other interventional applications. Founded in Berlin, the company was acquired by Hologic in January 2021 and now operates as part of Hologic's breast health portfolio. Its products are commercial-stage medical technologies rather than therapeutic drug programs.